343 related articles for article (PubMed ID: 36499714)
1. Pharmacomicrobiomics in Pediatric Oncology: The Complex Interplay between Commonly Used Drugs and Gut Microbiome.
Leardini D; Venturelli F; Baccelli F; Cerasi S; Muratore E; Brigidi P; Pession A; Prete A; Masetti R
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499714
[TBL] [Abstract][Full Text] [Related]
2. Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out.
Conti G; D'Amico F; Fabbrini M; Brigidi P; Barone M; Turroni S
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672796
[TBL] [Abstract][Full Text] [Related]
3. Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery.
Kamath S; Stringer AM; Prestidge CA; Joyce P
Expert Opin Drug Deliv; 2023; 20(10):1315-1331. PubMed ID: 37405390
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome in pediatric acute leukemia: from predisposition to cure.
Masetti R; Muratore E; Leardini D; Zama D; Turroni S; Brigidi P; Esposito S; Pession A
Blood Adv; 2021 Nov; 5(22):4619-4629. PubMed ID: 34610115
[TBL] [Abstract][Full Text] [Related]
5. Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism.
Dikeocha IJ; Al-Kabsi AM; Miftahussurur M; Alshawsh MA
FASEB J; 2022 Jun; 36(6):e22350. PubMed ID: 35579628
[TBL] [Abstract][Full Text] [Related]
6. Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs - is it a new perspective for personalized treatment of cancer patients?
Kaźmierczak-Siedlecka K; Bulman N; Ulasiński P; Sobocki BK; Połom K; Marano L; Kalinowski L; Skonieczna-Żydecka K
Gut Microbes; 2023 Dec; 15(2):2281017. PubMed ID: 37985748
[TBL] [Abstract][Full Text] [Related]
7. Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment.
Jia L; Huang S; Sun B; Shang Y; Zhu C
Front Endocrinol (Lausanne); 2023; 14():1149256. PubMed ID: 37033254
[TBL] [Abstract][Full Text] [Related]
8. Bugs as Drugs: Understanding the Linkage between Gut Microbiota and Cancer Treatment.
Rana D; Salave S; Perla A; Nadkarni A; Kolhe S; Jindal AB; Mandoli A; Dwivedi P; Benival D
Curr Drug Targets; 2022; 23(9):869-888. PubMed ID: 35264088
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy.
Chrysostomou D; Roberts LA; Marchesi JR; Kinross JM
Gastroenterology; 2023 Feb; 164(2):198-213. PubMed ID: 36309208
[TBL] [Abstract][Full Text] [Related]
10. Interaction between drugs and the gut microbiome.
Weersma RK; Zhernakova A; Fu J
Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
[TBL] [Abstract][Full Text] [Related]
11. Pharmacomicrobiomics-Guided Precision Oncology: A New Frontier of P4 (Predictive, Personalized, Preventive, and Participatory) Medicine and Microbiome-Based Therapeutics.
Arga KY; Attia H; Aziz RK
OMICS; 2024 Jan; 28(1):5-7. PubMed ID: 38190279
[TBL] [Abstract][Full Text] [Related]
12. Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment.
Chen HQ; Gong JY; Xing K; Liu MZ; Ren H; Luo JQ
Front Med (Lausanne); 2021; 8():742394. PubMed ID: 35127738
[TBL] [Abstract][Full Text] [Related]
13. Scheduled Empiric Antibiotics May Alter the Gut Microbiome and Nutrition Outcomes in Pediatric Intestinal Failure.
Talathi S; Wilkinson L; Meloni K; Shroyer M; Eipers P; Van Der Pol WJ; Martin C; Dimmitt R; Yi N; Morrow C; Galloway D
Nutr Clin Pract; 2021 Dec; 36(6):1230-1239. PubMed ID: 33078427
[TBL] [Abstract][Full Text] [Related]
14. Targeting microbiome, drug metabolism, and drug delivery in oncology.
Sumiyoshi A; Fujii H; Okuma Y
Adv Drug Deliv Rev; 2023 Aug; 199():114902. PubMed ID: 37263544
[TBL] [Abstract][Full Text] [Related]
15. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota modulation of chemotherapy efficacy and toxicity.
Alexander JL; Wilson ID; Teare J; Marchesi JR; Nicholson JK; Kinross JM
Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):356-365. PubMed ID: 28270698
[TBL] [Abstract][Full Text] [Related]
17. Emerging frontiers of antibiotics use and their impacts on the human gut microbiome.
Kumari R; Yadav Y; Misra R; Das U; Das Adhikari U; Malakar P; Dubey GP
Microbiol Res; 2022 Oct; 263():127127. PubMed ID: 35914416
[TBL] [Abstract][Full Text] [Related]
18. Precocious puberty and microbiota: The role of the sex hormone-gut microbiome axis.
Calcaterra V; Rossi V; Massini G; Regalbuto C; Hruby C; Panelli S; Bandi C; Zuccotti G
Front Endocrinol (Lausanne); 2022; 13():1000919. PubMed ID: 36339428
[TBL] [Abstract][Full Text] [Related]
19. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.
Ting NL; Lau HC; Yu J
Gut; 2022 Jul; 71(7):1412-1425. PubMed ID: 35277453
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects.
Leigh SJ; Lynch CMK; Bird BRH; Griffin BT; Cryan JF; Clarke G
Expert Opin Drug Metab Toxicol; 2022 Jan; 18(1):5-26. PubMed ID: 35176217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
